Sen. Tommy Tuberville sold Amgen (AMGN)
Sen. Tommy Tuberville (R-AL) · $15K–$50K · traded Apr 15, 2025
Why this is a committee overlap
Tuberville is a member of the Senate Committee on Health, Education, Labor, and Pensions, which oversees the Healthcare sector. Amgen is classified in the Drug Manufacturers - General industry.
An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.
- Transaction
- Sold (full)
- Amount
- $15K–$50K
- Owner
- Joint
- Traded
- Apr 15, 2025
- Disclosed
- May 15, 2025
- Days to disclose
- 30
- Asset type
- Stock
- As filed
- Amgen Inc
- Industry
- Drug Manufacturers - General · Healthcare
Other trades in this filing
- May 15, 2025$15K–$50K
$15K–$50K · Traded Apr 15, 2025 · disclosed May 15, 2025 · Joint
- May 15, 2025$1K–$15K
Sold (full) Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Apr 15, 2025 · disclosed May 15, 2025
Committee overlap: HELP - May 15, 2025$15K–$50K
$15K–$50K · Traded Apr 15, 2025 · disclosed May 15, 2025 · Joint
- May 15, 2025$15K–$50K
$15K–$50K · Traded Apr 15, 2025 · disclosed May 15, 2025 · Joint
- May 15, 2025$15K–$50K
$15K–$50K · Traded Apr 15, 2025 · disclosed May 15, 2025 · Joint
- May 15, 2025$15K–$50K
Sold (full) PayPal Holdings PYPL
$15K–$50K · Traded Apr 15, 2025 · disclosed May 15, 2025
- May 15, 2025$50K–$100K
Bought iShares Broad USD Investment Grade Corporate Bond ETF USIG
$50K–$100K · Traded Apr 15, 2025 · disclosed May 15, 2025
- May 15, 2025$15K–$50K
Sold (full) Constellation Brands STZ
$15K–$50K · Traded Apr 15, 2025 · disclosed May 15, 2025 · Joint
- May 15, 2025$15K–$50K
$15K–$50K · Traded Apr 15, 2025 · disclosed May 15, 2025 · Joint
- May 15, 2025$15K–$50K
Sold (full) Eli Lilly and Company LLY
$15K–$50K · Traded Apr 15, 2025 · disclosed May 15, 2025 · Joint
Committee overlap: HELP - May 15, 2025$15K–$50K
$15K–$50K · Traded Apr 15, 2025 · disclosed May 15, 2025 · Joint
- May 15, 2025$15K–$50K
$15K–$50K · Traded Apr 15, 2025 · disclosed May 15, 2025 · Joint
- May 15, 2025$15K–$50K
Sold (partial) The Goldman Sachs Group GS
$15K–$50K · Traded Apr 15, 2025 · disclosed May 15, 2025 · Joint
- May 15, 2025$15K–$50K
Sold (full) Archer-Daniels-Midland Company ADM
$15K–$50K · Traded Apr 15, 2025 · disclosed May 15, 2025 · Joint
Committee overlap: Agriculture - May 15, 2025$15K–$50K
Sold (full) JPMorgan Chase & JPM
$15K–$50K · Traded Apr 15, 2025 · disclosed May 15, 2025 · Joint
Recent Congress trades in AMGN
- Nov 2, 2026$15K–$50K
Sen. Sheldon Whitehouse (D-RI)
$15K–$50K · Traded Oct 15, 2026 · disclosed Nov 2, 2026 · Spouse
Committee overlap: Finance - Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Oct 1, 2026$1K–$15K
Rep. David J. Taylor (R-OH-2)
$1K–$15K · Traded Sep 22, 2026 · disclosed Oct 1, 2026
- Sep 5, 2026$1K–$15K
- Sep 5, 2026$1K–$15K
- Sep 2, 2026$1K–$15K
Sen. Sheldon Whitehouse (D-RI)
$1K–$15K · Traded Aug 12, 2026 · disclosed Sep 2, 2026 · Spouse
Committee overlap: Finance - Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jun 12, 2026$1K–$15K
Rep. David J. Taylor (R-OH-2)
$1K–$15K · Traded Jun 5, 2026 · disclosed Jun 12, 2026
Company context for AMGN
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
AMGN: Department of Health and Human Services contract award
NPLATE ADMINISTRATION KIT DEVELOPMENT FOR THE TREATMENT OF APPROVED INDICATIONS, INCLUDING ACUTE RADIATION SYNDROME (ARS)
2 congressional households disclosed purchases in the past 90 days. See the trades
AMGN: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
2 congressional households disclosed purchases in the past 90 days. See the trades
AMGN: Financial results
Filed 8-K for an event or period dated 2026-11-03. Financial results.
2 congressional households disclosed purchases in the past 90 days. See the trades
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.